[HTML][HTML] Predictors of non-sentinel lymph node metastasis in clinical early stage (cT1-2N0) breast cancer patients with 1-2 metastatic sentinel lymph nodes

A Lale, M Yur, H Özgül, EG Alkurt, N Yıldırım… - Asian Journal of …, 2020 - Elsevier
Objective The purpose of this study was to determine the risk factors that caused non-
sentinel lymph nodes (nonSLNs) metastasis by considering the clinicopathological …

Preoperative predictive factors affecting sentinel lymph node positivity in breast cancer and comparison of their effectiveness with existing nomograms

C Ceylan, HP Ozel, I Agackiran, BA Ozdemir, H Atas… - Medicine, 2022 - journals.lww.com
This study aimed to establish a strong regression model by revealing the preoperative
predictive factors for sentinel lymph node (SLN) positivity in patients with early stage breast …

Omitting completion axillary lymph node dissection after detection of sentinel node micrometastases in breast cancer: first results from the prospective SENOMIC trial

Y Andersson, L Bergkvist, J Frisell… - British Journal of …, 2021 - academic.oup.com
Background Completion axillary lymph node dissection has been abandoned widely among
patients with breast cancer and sentinel lymph node micrometastases, based on evidence …

Omission of axillary lymph node dissection for breast cancer patients with three or more positive sentinel lymph nodes

S Prathibha, MK White, M Kolbow, JYC Hui… - Breast Cancer Research …, 2024 - Springer
Abstract Purpose The ACOSOG Z0011 (Z11) trial assessed the benefit of axillary dissection
(ALND) for breast cancer patients with sentinel lymph node (SLN) metastases; however, Z11 …

Do clinical trials truly mirror their target population? An external validity analysis of national register versus trial data from the Swedish prospective SENOMIC trial on …

Y Andersson, L Bergkvist, J Frisell… - Breast Cancer Research …, 2019 - Springer
Purpose Increasing evidence suggests that completion axillary lymph node dissection
(ALND) may be omitted in breast cancer patients with limited axillary nodal metastases …

A novel nomogram and survival analysis for different lymph node status in breast cancer based on the SEER database

L Teng, J Du, S Yan, P Xu, J Liu, X Zhao, W Tao - Breast Cancer, 2024 - Springer
Introduction The axillary lymph node status (ALNS) and internal mammary lymph nodes
(IMLN) expression associated with breast cancer are closely linked to prognosis. This study …

Disparities in the use of sentinel lymph node dissection for early stage breast cancer

A Nayyar, PD Strassle, F Schlottmann, J Jadi… - Journal of Surgical …, 2020 - Elsevier
Background Clinical trials have long established the long-term safety of omitting axillary
lymph node dissection (ALND) after sentinel lymph node dissection (SLND) in patients with …

[PDF][PDF] The management of axillary lymph nodes in breast cancer–A retrospective single-centre study

EM Vrabie, M Alecu, C Cirimbei, C Daha, VM Prunoiu… - Chirurgia, 2021 - academia.edu
Prezentăm experienţa centrului nostru în tratamentul chirurgical al cancerului mamar,
comparând utilizarea disecţiei ganglionare axilare cu biopsia ganglionului limfatic santinelă …

242P Patterns of management of positive sentinel lymph nodes in breast cancer patients after the American College of Surgeons Oncology Group Z0011 trial: A …

MH El Charif - Annals of Oncology, 2022 - annalsofoncology.org
Background The management of axillary lymph nodes in breast cancer patients has
changed over the past years. The ACOSOG-Z0011 clinical trial introduced drastic changes …

Factors effecting the development of sentinel lymph node metastasis in clinical early-stage breast cancers (cT1-2N0): Clinical significance of primary tumor–skin …

L Zirek, A Lale, M Zirek, HN Lale, AC Yildirir, E Aygen - 2021 - annalsmedres.org
Aim: It was aimed to determine the demographic, clinicopathological and radiological
predictors that may be effective in the development of sentinel lymph node (SLN) metastasis …